Cargando…

Light-Triggered Cellular Delivery of Oligonucleotides

The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approache...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontturi, Leena-Stiina, van den Dikkenberg, Joep, Urtti, Arto, Hennink, Wim E., Mastrobattista, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410276/
https://www.ncbi.nlm.nih.gov/pubmed/30795565
http://dx.doi.org/10.3390/pharmaceutics11020090
_version_ 1783402210167619584
author Kontturi, Leena-Stiina
van den Dikkenberg, Joep
Urtti, Arto
Hennink, Wim E.
Mastrobattista, Enrico
author_facet Kontturi, Leena-Stiina
van den Dikkenberg, Joep
Urtti, Arto
Hennink, Wim E.
Mastrobattista, Enrico
author_sort Kontturi, Leena-Stiina
collection PubMed
description The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approached this challenge by developing a light-triggered liposomal delivery system for oligonucleotides based on a non-cationic and thermosensitive liposome with indocyanine green (ICG) as photosensitizer. The liposomes had efficient release properties, as 90% of the encapsulated oligonucleotides were released after 1-minute light exposure. Cell studies using an enhanced green fluorescent protein (EGFP)-based splicing assay with HeLa cells showed light-activated transfection with up to 70%–80% efficacy. Moreover, free ICG and oligonucleotides in solution transfected cells upon light induction with similar efficacy as the liposomal system. The light-triggered delivery induced moderate cytotoxicity (25%–35% reduction in cell viability) 1–2 days after transfection, but the cell growth returned to control levels in 4 days. In conclusion, the ICG-based light-triggered delivery is a promising method for oligonucleotides, and it can be used as a platform for further optimization and development.
format Online
Article
Text
id pubmed-6410276
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64102762019-03-29 Light-Triggered Cellular Delivery of Oligonucleotides Kontturi, Leena-Stiina van den Dikkenberg, Joep Urtti, Arto Hennink, Wim E. Mastrobattista, Enrico Pharmaceutics Article The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approached this challenge by developing a light-triggered liposomal delivery system for oligonucleotides based on a non-cationic and thermosensitive liposome with indocyanine green (ICG) as photosensitizer. The liposomes had efficient release properties, as 90% of the encapsulated oligonucleotides were released after 1-minute light exposure. Cell studies using an enhanced green fluorescent protein (EGFP)-based splicing assay with HeLa cells showed light-activated transfection with up to 70%–80% efficacy. Moreover, free ICG and oligonucleotides in solution transfected cells upon light induction with similar efficacy as the liposomal system. The light-triggered delivery induced moderate cytotoxicity (25%–35% reduction in cell viability) 1–2 days after transfection, but the cell growth returned to control levels in 4 days. In conclusion, the ICG-based light-triggered delivery is a promising method for oligonucleotides, and it can be used as a platform for further optimization and development. MDPI 2019-02-21 /pmc/articles/PMC6410276/ /pubmed/30795565 http://dx.doi.org/10.3390/pharmaceutics11020090 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kontturi, Leena-Stiina
van den Dikkenberg, Joep
Urtti, Arto
Hennink, Wim E.
Mastrobattista, Enrico
Light-Triggered Cellular Delivery of Oligonucleotides
title Light-Triggered Cellular Delivery of Oligonucleotides
title_full Light-Triggered Cellular Delivery of Oligonucleotides
title_fullStr Light-Triggered Cellular Delivery of Oligonucleotides
title_full_unstemmed Light-Triggered Cellular Delivery of Oligonucleotides
title_short Light-Triggered Cellular Delivery of Oligonucleotides
title_sort light-triggered cellular delivery of oligonucleotides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410276/
https://www.ncbi.nlm.nih.gov/pubmed/30795565
http://dx.doi.org/10.3390/pharmaceutics11020090
work_keys_str_mv AT kontturileenastiina lighttriggeredcellulardeliveryofoligonucleotides
AT vandendikkenbergjoep lighttriggeredcellulardeliveryofoligonucleotides
AT urttiarto lighttriggeredcellulardeliveryofoligonucleotides
AT henninkwime lighttriggeredcellulardeliveryofoligonucleotides
AT mastrobattistaenrico lighttriggeredcellulardeliveryofoligonucleotides